1. Home
  2. GCTK vs ATXG Comparison

GCTK vs ATXG Comparison

Compare GCTK & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • ATXG
  • Stock Information
  • Founded
  • GCTK 2001
  • ATXG 2014
  • Country
  • GCTK United States
  • ATXG China
  • Employees
  • GCTK N/A
  • ATXG N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • ATXG Professional Services
  • Sector
  • GCTK Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • GCTK Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • GCTK 5.1M
  • ATXG 5.4M
  • IPO Year
  • GCTK N/A
  • ATXG N/A
  • Fundamental
  • Price
  • GCTK $0.19
  • ATXG $0.80
  • Analyst Decision
  • GCTK
  • ATXG
  • Analyst Count
  • GCTK 0
  • ATXG 0
  • Target Price
  • GCTK N/A
  • ATXG N/A
  • AVG Volume (30 Days)
  • GCTK 8.8M
  • ATXG 5.8K
  • Earning Date
  • GCTK 05-14-2025
  • ATXG 02-14-2025
  • Dividend Yield
  • GCTK N/A
  • ATXG N/A
  • EPS Growth
  • GCTK N/A
  • ATXG N/A
  • EPS
  • GCTK N/A
  • ATXG N/A
  • Revenue
  • GCTK N/A
  • ATXG $4,549,310.00
  • Revenue This Year
  • GCTK N/A
  • ATXG N/A
  • Revenue Next Year
  • GCTK N/A
  • ATXG N/A
  • P/E Ratio
  • GCTK N/A
  • ATXG N/A
  • Revenue Growth
  • GCTK N/A
  • ATXG N/A
  • 52 Week Low
  • GCTK $0.16
  • ATXG $0.49
  • 52 Week High
  • GCTK $99.00
  • ATXG $1.18
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 28.80
  • ATXG 45.81
  • Support Level
  • GCTK $0.16
  • ATXG $0.79
  • Resistance Level
  • GCTK $0.24
  • ATXG $0.89
  • Average True Range (ATR)
  • GCTK 0.06
  • ATXG 0.06
  • MACD
  • GCTK 0.04
  • ATXG -0.00
  • Stochastic Oscillator
  • GCTK 5.84
  • ATXG 33.48

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: